journal article·2019-07Open access

Biomaterial-assisted local and systemic delivery of bioactive agents for bone repair

Yuze Zeng, Jiaul Hoque, Shyni Varghese

Acta Biomaterialia· Volume 93

Abstract

Although bone tissues possess an intrinsic capacity for repair, there are cases where bone healing is either impaired or insufficient, such as fracture non-union, osteoporosis, osteomyelitis, and cancers. In these cases, treatments like surgical interventions are used, either alone or in combination with bioactive agents, to promote tissue repair and manage associated clinical complications. Improving the efficacy of bioactive agents often requires carriers, with biomaterials being a pivotal player. In this review, we discuss the role of biomaterials in realizing the local and systemic delivery of biomolecules to the bone tissue. The versatility of biomaterials enables design of carriers with the desired loading efficiency, release profile, and on-demand delivery. Besides local administration, systemic administration of drugs is necessary to combat diseases like osteoporosis, warranting bone-targeting drug delivery systems. Thus, chemical moieties with the affinity towards bone extracellular matrix components like apatite minerals have been widely utilized to create bone-targeting carriers with better biodistribution, which cannot be achieved by the drugs alone. Bone-targeting carriers combined with the desired drugs or bioactive agents have been extensively investigated to enhance bone healing while minimizing off-target effects. Herein, these advancements in the field have been systematically reviewed. STATEMENT OF SIGNIFICANCE: Drug delivery is imperative when surgical interventions are not sufficient to address various bone diseases/defects. Biomaterial-assisted delivery systems have been designed to provide drugs with the desired loading efficiency, sustained release, and on-demand delivery to enhance bone healing. By surveying recent advances in the field, this review outlines the design of biomaterials as carriers for the local and systemic delivery of bioactive agents to the bone tissue. Particularly, biomaterials that bear chemical moieties with affinity to bone are attractive, as they can present the desired bioactive agents to the bone tissue efficiently and thus enhance the drug efficacy for bone repair.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone10.1016/j.addr.2012.05.006 ↗
2. Bone graft substitutes10.1586/17434440.3.1.49 ↗
3. Therapeutic approaches to bone diseases10.1126/science.289.5484.1508 ↗
4. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review10.1302/0301-620X.90B7.20498 ↗
5. Infection prevention in total knee and total hip arthroplasties
6. Recent advances in materials for extended-release antibiotic delivery system10.1038/ja.2011.58 ↗
7. Antimicrobial delivery systems for local infection prophylaxis in orthopedic-and trauma surgery10.1016/j.biomaterials.2015.02.020 ↗
8. Dendritic glycopolymer as drug delivery system for proteasome inhibitor bortezomib in a calcium phosphate bone cement: first steps toward a local therapy of osteolytic bone lesions10.1002/mabi.201500085 ↗
9. Biomimetic hydroxyapatite–drug nanocrystals as potential bone substitutes with antitumor drug delivery properties10.1002/adfm.200600361 ↗
10. Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis10.1056/NEJM200105103441904 ↗
11. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday10.1016/j.amjmed.2012.06.023 ↗
12. Delmas · 2005 · 58
13. Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density10.1359/jbmr.091035 ↗
14. Local delivery of adenosine receptor agonists to promote bone regeneration and defect healing
15. Cationic liposome–DNA complexes as gene delivery vectors: development and behaviour towards bone-like cells10.1016/j.actbio.2009.02.019 ↗
16. Simultaneous regeneration of articular cartilage and subchondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds10.1016/j.biomaterials.2011.03.041 ↗
17. Gene delivery to bone10.1016/j.addr.2012.03.013 ↗
18. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy10.1038/nm.3791 ↗
19. Chemically modified RNA induces osteogenesis of stem cells and human tissue explants as well as accelerates bone healing in rats10.1016/j.biomaterials.2016.02.018 ↗
20. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects10.1038/ncomms10376 ↗
21. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing10.1016/j.biomaterials.2017.06.001 ↗
22. Formulation delivery and stability of bone morphogenetic proteins for effective bone regeneration10.1007/s11095-017-2147-x ↗
23. Growth hormone, insulin-like growth factors, and the skeleton10.1210/er.2007-0036 ↗
24. Therapeutic bioactive microcarriers: co-delivery of growth factors and stem cells for bone tissue engineering10.1016/j.actbio.2013.09.042 ↗
25. Toward delivery of multiple growth factors in tissue engineering10.1016/j.biomaterials.2010.04.053 ↗
26. Growth factor-delivery systems for tissue engineering: a materials perspective10.1586/17434440.3.1.29 ↗
27. Strategies for controlled delivery of growth factors and cells for bone regeneration10.1016/j.addr.2012.01.016 ↗
28. Extracellular matrix-inspired growth factor delivery systems for bone regeneration10.1016/j.addr.2015.04.007 ↗
29. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft)10.1007/s00264-007-0418-6 ↗
30. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery10.1007/s00264-007-0424-8 ↗
31. A review of the clinical side effects of bone morphogenetic protein-210.1089/ten.teb.2015.0357 ↗
32. Comparison of micro-vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: bone morphogenetic protein-2 and alkaline phosphatase10.1016/j.biomaterials.2012.08.024 ↗
33. Collagen sponges for bone regeneration with rhBMP-210.1016/j.addr.2003.08.010 ↗
34. Fibrin glue as a drug delivery system10.1016/j.jconrel.2010.06.025 ↗
35. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects10.1016/j.biomaterials.2010.08.074 ↗
36. Electrospun silk-BMP-2 scaffolds for bone tissue engineering10.1016/j.biomaterials.2006.01.022 ↗
37. Hyaluronic acid-based clinical biomaterials derived for cell and molecule delivery in regenerative medicine10.1016/j.jconrel.2011.04.007 ↗
38. Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery10.1016/j.actbio.2013.09.039 ↗
39. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering10.1016/j.biomaterials.2009.03.024 ↗
40. Demineralized bone matrix in bone repair: history and use10.1016/j.addr.2012.06.008 ↗
41. Hydrogels derived from demineralized and decellularized bone extracellular matrix10.1016/j.actbio.2013.04.029 ↗
42. Self-assembly of pifithrin-α-loaded layered double hydroxide/chitosan nanohybrid composites as a drug delivery system for bone repair materials10.1039/C6TB02730J ↗
43. Biocompatible nanocomposite scaffolds based on copolymer-grafted chitosan for bone tissue engineering with drug delivery capability10.1016/j.msec.2017.02.112 ↗
44. Silk–hydroxyapatite nanoscale scaffolds with programmable growth factor delivery for bone repair10.1021/acsami.6b08180 ↗
45. Three-dimensional collagen/alginate hybrid scaffolds functionalized with a drug delivery system (DDS) for bone tissue regeneration10.1021/cm200733s ↗
46. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-210.1016/j.jconrel.2008.11.020 ↗
47. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-210.1016/j.actbio.2008.04.002 ↗
48. Natural-based nanocomposites for bone tissue engineering and regenerative medicine: a review10.1002/adma.201403354 ↗
49. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization10.1016/S0168-3659(02)00181-5 ↗
50. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier10.3390/polym3031377 ↗
51. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering10.1016/j.biomaterials.2008.04.031 ↗
52. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: a review10.1016/j.jconrel.2011.09.064 ↗
53. Mesoporous bioactive glasses: structure characteristics, drug/growth factor delivery and bone regeneration application10.1098/rsfs.2011.0121 ↗
54. Calcium phosphate cements as bone drug delivery systems: a review10.1016/j.jconrel.2006.04.007 ↗
55. Calcium phosphate biomaterials as bone drug delivery systems: a review10.1016/j.drudis.2010.05.003 ↗
56. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review10.1016/j.actbio.2011.11.017 ↗
57. Design of calcium phosphate ceramics for drug delivery applications in bone diseases: a review of the parameters affecting the loading and release of the therapeutic substance10.1016/j.jconrel.2017.02.012 ↗
58. Nanoscale hydroxyapatite particles for bone tissue engineering10.1016/j.actbio.2011.03.019 ↗
59. SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo10.1016/j.actbio.2013.07.009 ↗
60. Current trends in mesenchymal stem cell application in bone augmentation: a review of the literature10.1016/j.joms.2011.02.133 ↗
61. Human stem cell delivery for treatment of large segmental bone defects10.1073/pnas.0905444107 ↗
62. Concise review: Bridging the gap: Bone regeneration using skeletal stem cell-based strategies—Where are we now?10.1002/stem.1559 ↗
63. Injectable lipid emulsions—advancements, opportunities and challenges10.1208/s12249-010-9526-5 ↗
64. Polymeric micelle-templated synthesis of hydroxyapatite hollow nanoparticles for a drug delivery system10.1016/j.actbio.2009.12.014 ↗
65. Micelles and nanoparticles for ultrasonic drug and gene delivery10.1016/j.addr.2008.03.008 ↗
66. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
67. The stability of BMP loaded polyelectrolyte multilayer coatings on titanium10.1016/j.biomaterials.2013.03.067 ↗
68. Surface-mediated bone tissue morphogenesis from tunable nanolayered implant coatings10.1126/scitranslmed.3005576 ↗
69. Modulating hydrogel crosslink density and degradation to control bone morphogenetic protein delivery and in vivo bone formation10.1016/j.jconrel.2014.05.053 ↗
70. Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects10.1016/j.biomaterials.2010.02.052 ↗
71. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds10.1098/rsif.2009.0379 ↗
72. Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair10.1016/j.addr.2015.03.013 ↗
73. Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery10.1098/rsta.2011.0258 ↗
74. Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering10.1517/17425247.2013.808183 ↗
75. Development of collagen–hydroxyapatite scaffolds incorporating PLGA and alginate microparticles for the controlled delivery of rhBMP-2 for bone tissue engineering10.1016/j.jconrel.2014.11.021 ↗
76. 3D printing of calcium phosphate ceramics for bone tissue engineering and drug delivery10.1007/s10439-016-1678-3 ↗
77. A critical review of multifunctional titanium surfaces: new frontiers for improving osseointegration and host response, avoiding bacteria contamination10.1016/j.actbio.2018.08.013 ↗
78. Novel fabrication techniques to produce microspheres by thermally induced phase separation for tissue engineering and drug delivery10.1016/j.actbio.2007.09.011 ↗
79. Mechanical downsizing of a gadolinium (III)-based metal-organic framework for anticancer drug delivery10.1002/chem.201402244 ↗
80. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation10.1016/j.biomaterials.2009.10.059 ↗
81. Novel approach to fabricate porous sponges of poly (D, L-lactic-co-glycolic acid) without the use of organic solvents10.1016/0142-9612(96)87284-X ↗
82. Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin10.1016/j.actbio.2011.12.020 ↗
83. Chemically modified RNA activated matrices enhance bone regeneration10.1016/j.jconrel.2015.09.050 ↗
84. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections10.1016/j.biomaterials.2010.08.035 ↗
85. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels10.1016/j.jconrel.2011.06.027 ↗
86. Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 210.1016/j.actbio.2011.04.018 ↗
87. Heparin-conjugated fibrin as an injectable system for sustained delivery of bone morphogenetic protein-210.1089/ten.tea.2009.0390 ↗
88. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(l-lactic-co-glycolic acid) scaffold10.1016/j.biomaterials.2007.02.023 ↗
89. Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells10.1021/bm101041f ↗
90. Achieving controlled biomolecule-biomaterial conjugation10.1021/acs.chemrev.8b00253 ↗
91. Surface immobilization of bone morphogenetic protein 2 via a self-assembled monolayer formation induces cell differentiation10.1016/j.actbio.2011.10.019 ↗
92. Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers10.1016/j.actbio.2010.06.009 ↗
93. Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells10.1089/ten.tea.2010.0132 ↗
94. Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel10.1016/j.jconrel.2015.12.031 ↗
95. BMP-2 peptide-functionalized nanopatterned substrates for enhanced osteogenic differentiation of human mesenchymal stem cells10.1016/j.biomaterials.2013.06.019 ↗
96. Surface functionalization of titanium with carboxymethyl chitosan and immobilized bone morphogenetic protein-2 for enhanced osseointegration10.1021/bm900203w ↗
97. Heterobifunctional poly (Ethylene Glycol)–tethered bone morphogenetic protein-2–stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis10.1089/ten.2006.0209 ↗
98. A canine in vitro model for evaluation of marrow-derived mesenchymal stromal cell-based bone scaffolds10.1002/jbm.a.36430 ↗
99. Localized delivery of growth factors for bone repair10.1016/j.ejpb.2004.03.004 ↗
100. Site-directed immobilization of BMP-2: two approaches for the production of innovative osteoinductive scaffolds10.1021/acs.biomac.6b01407 ↗